CN106177768A - Chinese prescription of one group for the treatment of hyperthyroidism and preparation method thereof - Google Patents
Chinese prescription of one group for the treatment of hyperthyroidism and preparation method thereof Download PDFInfo
- Publication number
- CN106177768A CN106177768A CN201610672395.9A CN201610672395A CN106177768A CN 106177768 A CN106177768 A CN 106177768A CN 201610672395 A CN201610672395 A CN 201610672395A CN 106177768 A CN106177768 A CN 106177768A
- Authority
- CN
- China
- Prior art keywords
- radix
- fresh
- ethanol
- hyperthyroidism
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/342—Adenophora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Insects & Arthropods (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses Chinese prescription of one group for the treatment of hyperthyroidism and preparation method thereof, it is made up of following component and weight portion thereof: fresh Cymbidium ensifolium (L.) Sw. root stem 30 35, fresh Folium Stevlae Rebaudianae 50 60, Spica Prunellae 10 12, Galla Chinensis 10 12, Radix Adenophorae (Radix Glehniae) 13 15, Sargassum 12 15, field winter 13 15, Radix Ophiopogonis 13 15, Fructus Citri tangerinae core 13 15, the Radix Rehmanniae 13 15, pollen 10 12, Thallus Laminariae (Thallus Eckloniae) 10 12, Gekko Swinhonis 10 12, Rhizoma Curcumae 10 12, Herba Scutellariae Barbatae 10 12, Fructus Polygoni Orientalis 10 12, Bufo siccus 10 12, fresh Rhizoma dioscoreae 50 60.The Chinese prescription of one group for the treatment of hyperthyroidism of the present invention, Bufo siccus has effect of heat clearing away, toxin expelling, antitumor, defying age;It is equipped with Herba Scutellariae Barbatae, Spica Prunellae, Radix Ophiopogonis, there is inducing diuresis to remove edema, yin nourishing regulating menstruation, anticancer function.
Description
Technical field
The present invention relates to processing technique of Chinese herbs field, particularly relate to Chinese prescription and the preparation side thereof of one group for the treatment of hyperthyroidism
Method.
Background technology
At present Chinese medicine processing Mechanism Study is mainly used chemical and pharmacological method, and bioconversion, intestinal absorption
Transhipment, body absorption distribution and these new approaches of metabolism group and new method application are less.Therefore grind from Chinese medicine processing mechanism
Studying carefully present situation on the whole, comprehensive further investigation still is apparent not enough, and the elaboration majority of Chinese medicine processing mechanism is rested on this process
The two ends i.e. change of chemical composition and pharmacologic agent change, and to illustrate concoct mechanism key link--in before and after the process of preparing Chinese medicine
The research such as the Absorption And Metabolism of medicine active component is the most deep enough, before lacking a frame communication Chinese medicine processing in concocting mechanism elaborate process
Bridge--the research of active ingredient of Chinese herbs Absorption And Metabolism of relation between rear chemical composition change and pharmacological effect change.For oral use
Medicine is the Main Means of Chinese medicine, and it is that Chinese medicine produces biology that active ingredient of Chinese herbs absorbs with metabolism during gastrointestinal transit
The important step of effect, the most thoroughly illustrates the optimal point of penetration of Chinese medicine processing mechanism.And Chinese medicine generally requires and overcomes intestinal to inhale
The effect receiving barrier network could be absorbed, thus plays its therapeutical effect.Intestinal absorption barrier network is the important protection of body
System, can stop the absorption of poisonous substance and antigen, but be also the principal element limiting drug absorption, mainly by chemical barrier, physics
Barrier and biochemical barrier composition.Chemical barrier is mainly made up of the mucus of intestinal mucosa epithelial secretion, Digestive system etc., disappears containing various
Changing enzyme such as Lactose enzyme Phlorizin hydrolase (LPH), protide, many peptides and a lot of Chinese medicine ingredients can be broken by intestinal chemical barrier
Bad.Physical barriers is by structure, fully functional intestinal mucosa epithelium and is covered in the mucus on its surface and constitutes, and slime layer can be effectively
Protective epithelium cell microvillus, from mechanical, chemical damage, is also the obstacle of drug absorption simultaneously;And cell membrane and iuntercellular
Compact siro spinning technology be then the principal element limiting drug absorption to the permeability of medicine.Biochemical barrier is mainly by enterocyte
Metabolic enzyme and multi-efflux pumps are constituted, and such as II phase metabolic enzymes such as cytochrome enzyme and glucuronyl transferases, can will enter
Enter metabolism before the relative medicine metabolism of cell, i.e. body circulation;P-glycoprotein (P-gp), multidrug-associated protein (MRP), first ammonia
Intracellular relative medicine " pump " can be gone out extracellular by the discharging systems such as petrin (MTX), thus reduces drug concentration.Cause
This, carry out intestinal absorption barrier network to active component before and after Chinese medicine processing or the influence research of component Absorption And Metabolism, can be deeper
Illustrate Chinese medicine processing mechanism with entering, obtain the most objectively data from whole animal, cell and subcellsular level, for disclosing Chinese medicine
Concoct theoretical scientific meaning and new thinking and method are provided.
The most white etc. utilize esi-msn to analyze Radix Aconiti Lateralis Preparata to add the chemical composition change before and after adjuvant Radix Glycyrrhizae is concocted, take off
Show Radix Glycyrrhizae the attenuation mechanism in Radix Aconiti Lateralis Preparata concocting process.Research shows composition in Radix Glycyrrhizae diester-type alkaloids easily and in Radix Aconiti Lateralis Preparata
And thermal decomposition product generation transesterification reaction, generate the lipo-alkaloids that toxicity is less;There is a small amount of diester-type alkaloids simultaneously
With the precipitation that the chemical composition in Radix Glycyrrhizae defines slightly solubility, make the content of diester-type alkaloids in Radix Aconiti Lateralis Preparata reduce, thus reach
The purpose of attenuation.Bioconversion method application in Chinese medicine processing Mechanism Study is mainly reflected in 2 aspects.One is to send out
In the process of preparing Chinese medicine Mechanism Study of ferment Chinese medicine.Fermentation method is always one of Chinese medicine processing method, and it is by the effect of microorganism, in change
The original property of medicine of medicine, improves curative effect, reduces toxic and side effects, expands indication.Chinese medicine is concocted actually hence with fermentable
Being a kind of bioconversion reaction, available microbiology and biotechnology scheduling theory illustrate the principle of fermentation.As red in Wang Qiu based on
The cooked theory being effective substance research fermentation class Chinese medicine Massa Medicata Fermentata with secondary metabolites from microorganisms and bioconversion product;
The impact on Flos Carthami antioxidant activity is concocted in the microorganisms fermentations such as Feng Zhihua, and is inquired into its mechanism, result table
Bright Flos Carthami is concocted its anti-oxidation efficacy through the fermentation of Bacillus licheniformis C2-13 and is significantly improved, and its reason is probably C2-13
Produced various glycoside hydrolases, by many by the glucoside compound water of phenolic hydroxyl group with glucose condensation in Flos Carthami
Solve, make the number of phenolic hydroxyl group increase substantially, thus improve the non-oxidizability of Flos Carthami;In addition the aglycon produced after hydrolysis ratio is corresponding
Glucosides easily absorb, bioavailability is higher, is more beneficial for playing its pharmacological action.Two is to imitate in Chinese medicine processing forebody-afterbody
Answer in material base research and apply.Chinese medicine mainly with administered in oral forms, oral Chinese medicine composition play drug action it
Before, in addition to producing dynamically change in the process of preparing Chinese medicine, decoction process, after entering body, also want occurrence dynamics to change, this change
First process is exactly by human body intestinal canal enzyme and intestinal metabolism in digestive tract.
Chinese medicine processing has stir-fry method, preparation method, forges method, cooking process, duplicating method, baking process, stewing method etc., and these concocting methods are both needed to
Heating, heating process can make the chemical composition of Chinese medicine convert, thus change clinical efficacy;The Clinical practice of Chinese medicine is with decoction
It is main for being administered orally, and medicine is directly exposed to intestinal microbial population after entering enteric cavity, possibly together with various active enzyme in enteric cavity, and these intestinal microbial populations
With the existence of intestinal digestive enzyme, together with the liver of body, the joint effect conversion of chemical composition of Chinese materia medica;Extract oral is inhaled
Receipts process occurs mainly in small intestinal, before and after the process of preparing Chinese medicine chemical composition at intestinal absorption barrier network it may happen that interact and affect it
Absorption and transport, thus affect the bioavailability of medicine and the curative effect of processed product.Therefore author propose study hypothesis: " inside and outside
Chemical composition converts can affect the absorption and transport of chemical composition after the process of preparing Chinese medicine with the regulation and control of intestinal absorption barrier network and couple thereof,
Thus change the curative effect of Chinese medicine processing product ".
Sugar, as one of three class biomolecule most important in life entity, but lags behind nucleic acid and albumen to its understanding
Matter.Main cause is the multiformity of sugar structure.Sugar is connected by glycosidic bond, and glycosidic bond has two kinds of stereoisomeric forms in any ratio of α, β, due to
Each monosaccharide has several hydroxyl often to form branched structure.The synthesis of each glycosidic bond or fracture are by being positioned ad-hoc location
Glycosyl transferase or hydrolytic enzyme control, and this process is coarse, causes " microheterogeneity " of sugar chain so that it is separate pole
Its difficulty.The multiformity of sugar structure so that the quantity of information that it may carry is considerably beyond protein and nucleic acid.Saccharide compound
Being one of most important medicine of the mankind, the sugared drug molecule currently used includes various antibiotic, nucleoside, polysaccharide and glycolipid etc.,
For almost all of disease.The effective ingredient of China's Chinese medicine is also most relevant with sugar.Sugar in many plant extracts
Glycoside compound, is the sugar a kind of principal mode in nature existence, provides extremely abundant medicine resource for the mankind, common
Glucosides medicine such as cardiac glycoside, salicin, flavonoid glycoside etc. oneself be applied to clinic.In recent years, the rise of chemistry glycobiology research
With scientists to the progressively understanding of sugar function in life process, it is greatly promoted the innovation research of sugar medicine, occurs in that saliva
The new sugared medicines such as liquid acid derivative, saccharide vaccines, heparin mimetic.
Herba Lycopi has promoting blood flow to regulate menstruation, blood stasis dispelling eliminating carbuncle, effect of inducing diuresis to remove edema, for blood circulation promoting and blood stasis dispelling apoplexy due to endogenous wind conventional clinically
Medicine.Herba Lycopi mainly contains volatile oil, glucoside, tannin, resin, flavonoid glycoside, phenols, saponin, aminoacid, organic acid, water
Threose, galactose, fructose etc..Modern study shows that Herba Lycopi can significantly improve the abnormal erythrocyte rheology index of blood stasis animal, right
Rat chronic renal failure has an improvement result, simultaneously protecting the liver, the aspect such as hepatoprotective, anti-acute hepatic failure all have preferable activity.Warp
Crossing the unremitting effort of modern science, find that in the rhizome of Herba Lycopi, content of stachyose is high, Herba Lycopi's oligosaccharide is mainly by stachyose, hair
Stamen spends sugar and Raffinose to form, and wherein the content of stachyose and verbascose is obviously higher than the oligosaccharide in Semen sojae atricolor.Therefore, money
The abundant plant Herba Lycopi in source oneself develop the sustainable development natural product raw material becoming presently commercially available stachyose product rapidly.Herba Stachydis Japonicae
Sugar as emerging functional oligose, because of its slow down aging, regulation micro ecology of gastrointestinal tract balance, the immunity that improves, toxin expelling,
Lowering blood pressure aspect has physiological function, and its development and application is increasingly subject to pay attention to.Raffinose has improvement to atopic dermatitis
Effect, it is possible to as the active component of hepatopathy inhibitor, also has anti-hemopathic effect Proteinaceous, anti-, and raw to the mankind
Cell colonization has anticancer function.Raffinose has Stabilization to the system containing high unsaturated oils, therefore can using Raffinose as
Stabilizer adds the food grade emulsion containing high unsaturated materials to, and is provided without embedding form and for food, thus prolongs
The shelf life of long products.
Folium Stevlae Rebaudianae is herbaceos perennial, and province area is visitd by the Oman originating in Paraguay northeast.Containing big in its leaf
The natural sweetener of amount, so that Folium Stevlae Rebaudianae has huge economic worth.For many years, dry Stevia leaves is used as natural
Sweeting agent, then in the whole world, multiple countries go through to be used as food additive for its extract stevioside (STV) and Lay born of the same parents' enlightening glycosides A (RA)
Add agent.The U.S., respectively in 2008 and 2009, assert that the skilful compounds of highly purified stevioside is Generally Recognized as safe state.So far
Till, Folium Stevlae Rebaudianae is found that more than 100 kinds of compounds, most notable is exactly stevioside compounds, particularly content is
Abundant STV and RA.Additionally, Folium Stevlae Rebaudianae also has the Diterpene glucoside compounds of other low contents, according to being connected to C13 position
The difference of upper sugar chain, these compounds can be divided into four classes.Non-glucoside compound in Folium Stevlae Rebaudianae is labdane diterpenes.
Additionally, Folium Stevlae Rebaudianae also includes phenols, flavonoid, water soluble vitamins, phytosterol, triterpenes, volatile ingredient and biology
Alkaloid compound.
Summary of the invention
The object of the invention is contemplated to make up the defect of prior art, it is provided that the Chinese prescription of one group for the treatment of hyperthyroidism.
The present invention is achieved by the following technical solutions:
The Chinese prescription of one group for the treatment of hyperthyroidism, it is made up of following component and weight portion thereof:
Fresh Cymbidium ensifolium (L.) Sw. root stem 30-35, fresh Folium Stevlae Rebaudianae 50-60, Spica Prunellae 10-12, Galla Chinensis 10-12, Radix Adenophorae (Radix Glehniae) 13-15, Sargassum 12-
15, field winter 13-15,13-15 Radix Ophiopogonis, Fructus Citri tangerinae core 13-15, Radix Rehmanniae 13-15, pollen 10-12, Thallus Laminariae (Thallus Eckloniae) 10-12, Gekko Swinhonis 10-12, Rhizoma Curcumae
10-12, Herba Scutellariae Barbatae 10-12, Fructus Polygoni Orientalis 10-12, Bufo siccus 10-12, fresh Rhizoma dioscoreae 50-60.
The Chinese prescription of one group of described treatment hyperthyroidism, is made up of the following step:
1), respectively by Spica Prunellae, Galla Chinensis, Radix Adenophorae (Radix Glehniae), Sargassum, Tian Dong, Radix Ophiopogonis, Fructus Citri tangerinae core, the Radix Rehmanniae, Thallus Laminariae (Thallus Eckloniae), Gekko Swinhonis, Rhizoma Curcumae, half
Lotus, Fructus Polygoni Orientalis, Bufo siccus are pulverized, and add the ethanol of 3-5 times of 60-70% after mixing, adjust pH9.0-10.0, reflux, extract, 2-3 time, often
Secondary extraction 1.5-3 hour, collects extracting solution respectively and residue is standby;
2), by gained mixing residue in step 1, add the ethanol of 3-5 times amount 70-95%, adjust pH5.0-6.0, reflux, extract, 2-4
Secondary, extract 1.5-2.5 hour every time, collect extracting solution standby;
3), by step 1 gained extracting solution by centrifugation, filter after supernatant, reclaim after ethanol, regulate pH4.0-7.0, then through from
The heart, filtration, rinse removing impurity, 70-90% ethanol elution respectively with pure water, 10-30% ethanol after macroporous resin adsorption, collect
Eluent, obtains concentrated solution standby after concentration;
4), by extracting solution in step 2 by centrifugation, filter after supernatant, reclaim after ethanol, redissolve, decolouring, neutralize solution in
It is centrifuged after property, is filtered to remove tannin, take supernatant, regulate pH10-12, after macroporous resin adsorption, with pure water, 10-30% ethanol
Rinse respectively and remove impurity, 70-90% ethanol elution, collect eluent, be concentrated to give concentrated solution standby;
5), fresh Cymbidium ensifolium (L.) Sw. root stem, fresh Folium Stevlae Rebaudianae, fresh Rhizoma dioscoreae are rinsed well after, homogenate, mistake are shredded and be squeezed into drip except excessive moisture,
After filtering slag with pollen, step 3, prepare concentrated solution in 4 and mix, vacuum dried prepare, be distributed into bag, every bag 50-55 gram, warm
Mixing in water for oral taking, every day one bag.
The invention have the advantage that
1, the Chinese prescription of one group for the treatment of hyperthyroidism of the present invention, filters after fresh Cymbidium ensifolium (L.) Sw. root stem, fresh Folium Stevlae Rebaudianae, fresh Rhizoma dioscoreae are rushed fresh squeezing
Slagging-off, leaves and takes the beneficiating ingredient that tissue is fine and smooth, is vacuum dried after mixing with Chinese medicine extract, as a kind of carrier mass,
To improve the ratio of concentrated solution solid content, effective ingredient is played package action, and dried powder can be increased as carrier
The resistance to water soak of shape finished product and storing stability.
2, the Chinese prescription of one group for the treatment of hyperthyroidism of the present invention, containing substantial amounts of natural sweetener in its leaf of Folium Stevlae Rebaudianae,
Improve the mouthfeel that Chinese medicine is pained;In addition, Folium Stevlae Rebaudianae also includes phenols, flavonoid, water soluble vitamins, phytosterol, three
Terpenoid, volatile ingredient and alkaloid compound, strengthen health-care effect.
3, the Chinese prescription of one group for the treatment of hyperthyroidism of the present invention, in the rhizome of contained Herba Lycopi, content of stachyose is high, Herba Lycopi
Oligosaccharide is mainly made up of stachyose, verbascose and Raffinose.Stachyose is as emerging functional oligose, and it is delaying
Old and feeble, regulation micro ecology of gastrointestinal tract balance, the immunity that improves, toxin expelling, lowering blood pressure aspect have splendid physiological function;Cotton
Son sugar has improvement result to atopic dermatitis, it is possible to as the active component of hepatopathy inhibitor, also have anti-blood Proteinaceous, anti-
Sick effect, and Human germ cells is had anticancer function.
4, the Chinese prescription of one group for the treatment of hyperthyroidism of the present invention, Bufo siccus has the merit of heat clearing away, toxin expelling, antitumor, defying age
Effect;It is equipped with Herba Scutellariae Barbatae, Spica Prunellae, Radix Ophiopogonis, there is inducing diuresis to remove edema, yin nourishing regulating menstruation, anticancer function.
Detailed description of the invention
The Chinese prescription of one group for the treatment of hyperthyroidism, it is made up of following component and weight portion thereof:
Fresh Cymbidium ensifolium (L.) Sw. root stem 30, fresh Folium Stevlae Rebaudianae 50, Spica Prunellae 10, Galla Chinensis 10, Radix Adenophorae (Radix Glehniae) 13, Sargassum 12, field winter 13, Radix Ophiopogonis 13, Fructus Citri tangerinae
Core 13, the Radix Rehmanniae 13, pollen 10, Thallus Laminariae (Thallus Eckloniae) 10, Gekko Swinhonis 10, Rhizoma Curcumae 10, Herba Scutellariae Barbatae 10, Fructus Polygoni Orientalis 10, Bufo siccus 10, fresh Rhizoma dioscoreae 50.
The Chinese prescription of one group of described treatment hyperthyroidism, is made up of the following step:
1), respectively by Spica Prunellae, Galla Chinensis, Radix Adenophorae (Radix Glehniae), Sargassum, Tian Dong, Radix Ophiopogonis, Fructus Citri tangerinae core, the Radix Rehmanniae, Thallus Laminariae (Thallus Eckloniae), Gekko Swinhonis, Rhizoma Curcumae, half
Lotus, Fructus Polygoni Orientalis, Bufo siccus are pulverized, and add the ethanol of 3 times 60% after mixing, adjust pH9.0, reflux, extract, 2 times, extract 1.5 little every time
Time, collect extracting solution respectively and residue is standby;
2), by gained mixing residue in step 1, add the ethanol of 3 times amount 70%, adjust pH5.0, reflux, extract, 2 times, extract every time
1.5 hours, collect extracting solution standby;
3), by step 1 gained extracting solution by centrifugation, filter after supernatant, reclaim after ethanol, regulate pH4.0, more by centrifugation,
Filter, after macroporous resin adsorption, rinse removing impurity, 70% ethanol elution respectively with pure water, 10% ethanol, collect eluent, dense
Concentrated solution is obtained standby after contracting;
4), by extracting solution in step 2 by centrifugation, filter after supernatant, reclaim after ethanol, redissolve, decolouring, neutralize solution in
It is centrifuged after property, is filtered to remove tannin, take supernatant, regulate pH10, after macroporous resin adsorption, rush respectively with pure water, 10% ethanol
Eccysis decontamination, 70% ethanol elution, collect eluent, be concentrated to give concentrated solution standby;
5), fresh Cymbidium ensifolium (L.) Sw. root stem, fresh Folium Stevlae Rebaudianae, fresh Rhizoma dioscoreae are rinsed well after, homogenate, mistake are shredded and be squeezed into drip except excessive moisture,
After filtering slag with pollen, step 3, prepare concentrated solution in 4 and mix, vacuum dried prepared, be distributed into bag, 50 grams every bag, warm water
Take after mixing it with water, every day one bag.
Claims (2)
1. the Chinese prescription of one group for the treatment of hyperthyroidism, it is characterised in that it is made up of following component and weight portion thereof:
Fresh Cymbidium ensifolium (L.) Sw. root stem 30-35, fresh Folium Stevlae Rebaudianae 50-60, Spica Prunellae 10-12, Galla Chinensis 10-12, Radix Adenophorae (Radix Glehniae) 13-15, Sargassum 12-
15, field winter 13-15,13-15 Radix Ophiopogonis, Fructus Citri tangerinae core 13-15, Radix Rehmanniae 13-15, pollen 10-12, Thallus Laminariae (Thallus Eckloniae) 10-12, Gekko Swinhonis 10-12, Rhizoma Curcumae
10-12, Herba Scutellariae Barbatae 10-12, Fructus Polygoni Orientalis 10-12, Bufo siccus 10-12, fresh Rhizoma dioscoreae 50-60.
The Chinese prescription of one group for the treatment of hyperthyroidism the most according to claim 1, it is characterised in that be made up of the following step:
1), respectively by Spica Prunellae, Galla Chinensis, Radix Adenophorae (Radix Glehniae), Sargassum, Tian Dong, Radix Ophiopogonis, Fructus Citri tangerinae core, the Radix Rehmanniae, Thallus Laminariae (Thallus Eckloniae), Gekko Swinhonis, Rhizoma Curcumae, half
Lotus, Fructus Polygoni Orientalis, Bufo siccus are pulverized, and add the ethanol of 3-5 times of 60-70% after mixing, adjust pH9.0-10.0, reflux, extract, 2-3 time, often
Secondary extraction 1.5-3 hour, collects extracting solution respectively and residue is standby;
2), by gained mixing residue in step 1, add the ethanol of 3-5 times amount 70-95%, adjust pH5.0-6.0, reflux, extract, 2-4
Secondary, extract 1.5-2.5 hour every time, collect extracting solution standby;
3), by step 1 gained extracting solution by centrifugation, filter after supernatant, reclaim after ethanol, regulate pH4.0-7.0, then through from
The heart, filtration, rinse removing impurity, 70-90% ethanol elution respectively with pure water, 10-30% ethanol after macroporous resin adsorption, collect
Eluent, obtains concentrated solution standby after concentration;
4), by extracting solution in step 2 by centrifugation, filter after supernatant, reclaim after ethanol, redissolve, decolouring, neutralize solution in
It is centrifuged after property, is filtered to remove tannin, take supernatant, regulate pH10-12, after macroporous resin adsorption, with pure water, 10-30% ethanol
Rinse respectively and remove impurity, 70-90% ethanol elution, collect eluent, be concentrated to give concentrated solution standby;
5), fresh Cymbidium ensifolium (L.) Sw. root stem, fresh Folium Stevlae Rebaudianae, fresh Rhizoma dioscoreae are rinsed well after, homogenate, mistake are shredded and be squeezed into drip except excessive moisture,
After filtering slag with pollen, step 3, prepare concentrated solution in 4 and mix, vacuum dried prepare, be distributed into bag, every bag 50-55 gram, warm
Mixing in water for oral taking, every day one bag.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610672395.9A CN106177768A (en) | 2016-08-16 | 2016-08-16 | Chinese prescription of one group for the treatment of hyperthyroidism and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610672395.9A CN106177768A (en) | 2016-08-16 | 2016-08-16 | Chinese prescription of one group for the treatment of hyperthyroidism and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106177768A true CN106177768A (en) | 2016-12-07 |
Family
ID=57521712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610672395.9A Pending CN106177768A (en) | 2016-08-16 | 2016-08-16 | Chinese prescription of one group for the treatment of hyperthyroidism and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106177768A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1626220A (en) * | 2004-08-12 | 2005-06-15 | 赵立明 | Chinese herbal medicine for treating hyperthyroidism |
CN104800556A (en) * | 2015-05-19 | 2015-07-29 | 李汶峰 | Traditional Chinese medicine for treating hyperthyroidism |
-
2016
- 2016-08-16 CN CN201610672395.9A patent/CN106177768A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1626220A (en) * | 2004-08-12 | 2005-06-15 | 赵立明 | Chinese herbal medicine for treating hyperthyroidism |
CN1273181C (en) * | 2004-08-12 | 2006-09-06 | 赵立明 | Chinese herbal medicine for treating hyperthyroidism |
CN104800556A (en) * | 2015-05-19 | 2015-07-29 | 李汶峰 | Traditional Chinese medicine for treating hyperthyroidism |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103103099B (en) | A kind of compound Dendrobium huoshanense-cistanchganoderma ganoderma health promoting wine and production technology | |
CN107412721B (en) | Blood sugar-reducing bitter gourd polypeptide compound capsule and preparation method thereof | |
CN103301412A (en) | Traditional Chinese medicine composition for treating alcoholic liver | |
CN103127158B (en) | Cyclocarya paliurus extract and application thereof | |
CN101507757A (en) | Compound Chinese medicine for treating diabetes | |
CN103006878A (en) | Fresh rehmannia root total glycoside extract, preparation method and application thereof | |
CN106075370A (en) | Chinese prescription of one group for the treatment of acute/chronic pharyngitis and preparation method thereof | |
CN105338993A (en) | Composition for preventing, relieving or treating colitis, containing complex extracts | |
CN106177726A (en) | A kind of foot bath package side dispelling internal dampness and preparation method thereof | |
CN106063862A (en) | Chinese prescription of one group for the treatment of trigeminal neuralgia and preparation method thereof | |
CN104161977B (en) | It is a kind of to be used to prevent and treat Chinese medicine composition of infectious coryza of chicken and preparation method thereof | |
CN103749818A (en) | Rhizoma polygonati healthcare tea with hypoglycemic and hypolipidemic effects and preparation method thereof | |
CN101987192A (en) | Traditional Chinese medicine composition for protecting liver, preparation method and quality control method thereof | |
CN105194421A (en) | Self-heal health-care oral solution capable of reducing blood fat and preparation method thereof | |
CN106075163A (en) | One treats bronchial asthma in acute attack Chinese prescription and preparation method thereof | |
CN106237277A (en) | Chinese prescription of one group for the treatment of acute toothache and preparation method thereof | |
CN106109856A (en) | Pure Chinese prescription of one group for the treatment of toothache and preparation method thereof | |
CN100577193C (en) | Health product for sobering-up | |
CN106177768A (en) | Chinese prescription of one group for the treatment of hyperthyroidism and preparation method thereof | |
CN1565467A (en) | Use of cornel and its extract in preparation alpha-glucosidase inhibitor medicine | |
CN112121074B (en) | Compound plant extract preparation for preventing and controlling porcine viral diseases and application thereof | |
CN106138888A (en) | A kind of broad-spectrum Chinese medicine medicine for preventing prescription and preparation method thereof | |
CN106138696A (en) | A kind of prescription treating asthenic cold type diabetes and preparation method thereof | |
CN106138317A (en) | Chinese prescription of one group for the treatment of child bedwetting and preparation method thereof | |
CN106138753A (en) | A kind of Chinese prescription of regulating blood lipoid and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161207 |